You are here

IGF OT IGF TRANSCATHETER CAVOPULMONARY BYPASS ENDOGRAFT SBIR TOPIC DIRECT TO PHASE II IGF OT IGF

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 268201600042C-0-0-0
Agency Tracking Number: N44HL160042
Amount: $2,999,984.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NHLBI
Solicitation Number: N/A
Timeline
Solicitation Year: 2016
Award Year: 2016
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
39 ABBOT ST
ANDOVER, MA 18104
United States
DUNS: 025267580
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 STACY TURNER
 (978) 973-7615
 nasser.rafiee@transmuralsystems.com
Business Contact
 STACY TURNER
Phone: (978) 973-7615
Email: nasser.rafiee@transmuralsystems.com
Research Institution
N/A
Abstract

Extra anatomic bypass or vascular shunts divert blood flow In congenital heart disease these surgical procedures are critical for management Children born with one functional ventricle or cardiac pumping chamber require two to three major cardiac surgery procedures for palliation The management goal is to divert systemic venous return deoxygenated blood from the heart directly to pulmonary artery circulation such that the single ventricle can pump oxygenated blood returning to the heart from the lungs to the body These multiple surgical procedures carry significant morbidity and mortality as well as incur substantial hospital costs secondary to lengthy hospital stays A minimally invasive transcatheter approach would revolutionize the management of these children with congenital heart disease No commercial alternatives exist for off label medical use Children born with single ventricle physiology represent of congenital heart disease diagnosed in childhood and have a birth incidence of approximately per In the United States this represents approximately children born each year The commercial market is small enough to discourage the early development costs of a transcatheter cavopulmonary bypass endograft There is a considerable unmet need for a purpose built cavopulmonary anastomosis device

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government